Body mass index does not influence post-treatment survival in early stage endometrial cancer: Results from the MRC ASTEC trial

European Journal of Cancer

Volumn 48, Issue 6, 2012, Pages 853-864

  Crosbie, Emma J ^a   Roberts, Chris ^a   Qian, Wendi ^b   Swart, Ann Marie ^b   Kitchener, Henry C ^a   Renehan, Andrew G ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

Body mass index; Endometrial cancer; Obesity; Treatment outcome

Indexed keywords

ABDOMINAL HYSTERECTOMY; ADULT; AGED; ARTICLE; BODY MASS; BRACHYTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; EARLY CANCER; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; OBESITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION SICKNESS; RECURRENCE FREE SURVIVAL; RISK FACTOR; SUBTOTAL HYSTERECTOMY;

ANALYSIS OF VARIANCE; BODY MASS INDEX; CARCINOMA, ENDOMETRIOID; ENDOMETRIAL NEOPLASMS; FEMALE; GREAT BRITAIN; HUMANS; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS;

EID: 84859099207     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.10.003     Document Type: Article

References (47)

1. Cancer Research UK Cancer Stats for 2007. < http://info. cancerresearchuk.org/cancerstats/types/uterus/incidence/ >; 2007 [accessed 6.04.2011].
2. F. Berrino, R. De Angelis, and M. Sant Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study Lancet Oncol 8 9 2007 773 783 (Pubitemid 47321600)
3. A. Renehan, M. Tyson, M. Egger, R.F. Heller, and M. Zwahlen Body mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies Lancet 371 9612 2008 569 578 (Pubitemid 351232031)
4. E.J. Crosbie, M. Zwahlen, H.C. Kitchener, M. Egger, and A.G. Renehan Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis Cancer Epidemiol Biomarkers Prev 19 12 2010 3119 3130
5. E.E. Calle, and R. Kaaks Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms Nat Rev Cancer 4 8 2004 579 591 (Pubitemid 39025053)
6. D.L. Roberts, C. Dive, and A.G. Renehan Biological mechanisms linking obesity and cancer risk: new perspectives Annu Rev Med 61 2010 301 316
7. E.E. Calle, C. Rodriguez, K. Walker-Thurmond, and M.J. Thun Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults N Engl J Med 348 17 2003 1625 1638 (Pubitemid 36459468)
8. G.K. Reeves, K. Pirie, and V. Beral Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study BMJ 2007
9. A.R. Carmichael Obesity and prognosis of breast cancer Obes Rev 7 4 2006 333 340 (Pubitemid 44564304)
10. M. Protani, M. Coory, and J.H. Martin Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis Breast Cancer Res Treat 123 3 2010 627 635
11. M. Ewertz, M.B. Jensen, and K.A. Gunnarsdottir Effect of obesity on prognosis after early-stage breast cancer J Clin Oncol 29 1 2011 25 31
12. I. Sestak, W. Distler, and J.F. Forbes Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial J Clin Oncol 28 21 2010 3411 3415
13. J.J. Dignam, B.N. Polite, and G. Yothers Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer J Natl Cancer Inst 98 22 2006 1647 1654 (Pubitemid 44811647)
14. A.M. Haydon, R.J. Macinnis, D.R. English, H. Morris, and G.G. Giles Physical activity, insulin-like growth factor 1, insulin-like growth factor binding protein 3, and survival from colorectal cancer Gut 55 5 2006 689 694
15. F.A. Sinicrope, N.R. Foster, D.J. Sargent, M.J. O'Connell, and C. Rankin Obesity is an independent prognostic variable in colon cancer survivors Clin Cancer Res 16 6 2010 1884 1893
16. A. Kjaerbye-Thygesen, K. Frederiksen, and E.V. Hogdall Smoking and overweight: negative prognostic factors in stage III epithelial ovarian cancer Cancer Epidemiol Biomarkers Prev 15 4 2006 798 803
17. J.C. Pavelka, R.S. Brown, and B.Y. Karlan Effect of obesity on survival in epithelial ovarian cancer Cancer 107 7 2006 1520 1524 (Pubitemid 44546912)
18. Z. Gong, I. Agalliu, D.W. Lin, J.L. Stanford, and A.R. Kristal Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men Cancer 109 6 2007 1192 1202 (Pubitemid 46435400)
19. E. Everett, H. Tamimi, and B. Greer The effect of body mass index on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer Gynecol Oncol 90 1 2003 150 157 (Pubitemid 37338090)
20. F. Martra, C. Kunos, and H. Gibbons Adjuvant treatment and survival in obese women with endometrial cancer: an international collaborative study Am J Obstet Gynecol 198 1 2008 89 [e1-8]
21. K. Munstedt, M. Wagner, U. Kullmer, A. Hackethal, and F.E. Franke Influence of body mass index on prognosis in gynecological malignancies Cancer Causes Control 19 9 2008 909 916
22. V.E. von Gruenigen, C. Tian, and H. Frasure Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma: a Gynecologic Oncology Group study Cancer 107 12 2006 2786 2791 (Pubitemid 44937031)
23. J.V. Bokhman Two pathogenetic types of endometrial carcinoma Gynecol Oncol 15 1 1983 10 17 (Pubitemid 13194678)
24. H. Kitchener, A.M. Swart, Q. Qian, C. Amos, and M.K. Parmar Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study Lancet 373 9658 2009 125 136
25. P. Blake, A.M. Swart, and J. Orton Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis Lancet 373 9658 2009 137 146
26. E. von Elm, D.G. Altman, and M. Egger The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies Lancet 370 9596 2007 1453 1457
27. L.M. McShane, D.G. Altman, and W. Sauerbrei REporting recommendations for tumour MARKer prognostic studies (REMARK) Br J Cancer 93 4 2005 387 391 (Pubitemid 43080010)
28. M. Wells Minimum dataset for the histopathological reporting of atypical hyperplasia and adenocarcinoma in endometrial biopsy and currettage specimens and for endometrial cancer in hysterectomy specimens. Standards and Minimum Datasets for Reporting Cancers 2001 Royal College of Pathologists London
29. J.L. Benedet, H. Bender, H. Jones 3rd, H.Y. Ngan, and S. Pecorelli FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology Int J Gynaecol Obstet 70 2 2000 209 262
30. D.W. Hosmer, S. Lemeshow, and S. May Applied survival analysis: regression modeling of time to event data 2008 Wiley New York
31. Coviello E, Moran J. 'STCOXGOF': module to produce goodness-of-fit test and plot after a Cox model. < http://fmwww.bc.edu/RePEc/bocode/s >; 2008.
32. J.P. Fine, and R.J. Gray A proportional hazards model for the subdistribution of a competing risk J Am Stat Assoc 94 1999 496 509
33. M.F. Kuczmarski, R.J. Kuczmarski, and M. Najjar Effects of age on validity of self-reported height, weight, and body mass index: findings from the Third National Health and Nutrition Examination Survey, 1988-1994 J Am Diet Assoc 101 1 2001 28 34 [quiz 35-6] (Pubitemid 33712693)
34. M.F. Leitzmann, S.C. Moore, and A. Koster Waist circumference as compared with body-mass index in predicting mortality from specific causes PLoS One 6 4 2011 e18582
35. S.J. Freedland, and E.A. Platz Obesity and prostate cancer: making sense out of apparently conflicting data Epidemiol Rev 29 2007 88 97 (Pubitemid 47229642)
36. A.J. Canchola, E.T. Chang, and L. Bernstein Body size and the risk of ovarian cancer by hormone therapy use in the California Teachers Study cohort Cancer Causes Control 21 12 2010 2241 2248
37. S.M. Temkin, J.C. Pezzullo, M. Hellmann, Y.C. Lee, and O. Abulafia Is body mass index an independent risk factor of survival among patients with endometrial cancer? Am J Clin Oncol 30 1 2007 8 14 (Pubitemid 46213818)
38. K.K. Mauland, J. Trovik, and E. Wik High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer Br J Cancer 104 6 2011 921 926
39. S.C. Modesitt, C. Tian, and R. Kryscio Impact of body mass index on treatment outcomes in endometrial cancer patients receiving doxorubicin and cisplatin: a Gynecologic Oncology Group study Gynecol Oncol 105 1 2007 59 65 (Pubitemid 46441440)
40. R.J. Hunter, M.A. Navo, and P.H. Thaker Dosing chemotherapy in obese patients: actual versus assigned body surface area (BSA) Cancer Treat Rev 35 1 2009 69 78
41. N.T. Kizer, P.H. Thaker, and F. Gao The effects of body mass index on complications and survival outcomes in patients with cervical carcinoma undergoing curative chemoradiation therapy Cancer 117 5 2011 948 956
42. J.E. Paes, K. Hua, and R. Nagy The relationship between body mass index and thyroid cancer pathology features and outcomes: a clinicopathological cohort study J Clin Endocrinol Metab 95 9 2010 4244 4250
43. S. Brookman-May, F. Kendel, and B. Hoschke Impact of body mass index and weight loss on cancer-specific and overall survival in patients with surgically resected renal cell carcinoma Scand J Urol Nephrol 45 1 2011 5 14
44. A. Haferkamp, M. Pritsch, and J. Bedke The influence of body mass index on the long-term survival of patients with renal cell carcinoma after tumour nephrectomy BJU Int 101 10 2008 1243 1246 (Pubitemid 351549624)
45. H.G. Jeon, I.G. Jeong, and J.H. Lee Prognostic value of body mass index in Korean patients with renal cell carcinoma J Urol 183 2 2010 448 454
46. A.S. Parker, C.M. Lohse, and J.C. Cheville Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma Urology 68 4 2006 741 746 (Pubitemid 44633396)
47. A.J. Schrader, J. Rustemeier, and J.C. Rustemeier Overweight is associated with improved cancer-specific survival in patients with organ-confined renal cell carcinoma J Cancer Res Clin Oncol 135 12 2009 1693 1699